Company news
Biorestorative Therapies, Inc. (NASDAQ:BRTX) news
Every Biorestorative Therapies, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 3
BioRestorative Therapies Announces the Appointment of Robert Paccasassi to Vice President of Quality Assurance/Regulatory Compliance
January 11, 2022
BioRestorative Therapies Awarded an STTR Phase I Grant to Explore the Therapeutic Effects of PEG-Peptide Hydrogel-Encapsulated Hypoxic Bone Marrow Stem Cells
January 4, 2022
BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
December 21, 2021
BioRestorative Therapies, Inc. Releases Year-End Message
December 20, 2021
BioRestorative Therapies Announces Filing of Ten Patent Applications Related to its BRTX-100 Program
December 2, 2021
BioRestorative Therapies Enters into Letter of Intent with PRC Clinical
November 19, 2021
BioRestorative Therapies Appoints Robert Kristal as Chief Financial Officer
November 10, 2021
BioRestorative Therapies Announces Closing of $23 Million Public Offering
November 9, 2021
BioRestorative Therapies Announces Nomination of Two New Members to the Board of Directors
October 26, 2021
BioRestorative Therapies Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq
October 26, 2021
BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program
September 23, 2021
BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program
September 2, 2021
BioRestorative Therapies Receives Patent in Japan Related to its Off-the-Shelf ThermoStem® Program
August 31, 2021
BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
August 9, 2021
BioRestorative Therapies Expanding its Cell Therapy Manufacturing Facility
May 10, 2021
BioRestorative Therapies Announces Compliance with SEC Reporting Requirements and “Stop Sign” Removal
May 3, 2021
BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of Directors
April 5, 2021
BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to its Off-the-Shelf ThermoStem® Program
March 31, 2021
BioRestorative Therapies Announces Notices of Allowance for Three Patent Applications for its Off-the-Shelf ThermoStem® Program
March 22, 2021
BioRestorative Therapies Announces Filing of 2019 Annual Report on Form 10-K
March 18, 2021
BioRestorative Therapies Emerges from Chapter 11 Reorganization
November 20, 2020
BioRestorative Therapies Receives Patent in Israel For Its Metabolic Program
December 12, 2019